SCHEMBL5192934

SCHEMBL5192934

CC(NC(=O)CC1CN(S(=O)(=O)N(C)C)CCN1c1ccnc(-n2ccnc2)n1)c1ccc2c(c1)OCO2

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 20/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5195037 0.92 NOS2 (0.78) NOS2
SCHEMBL5194513 0.92 NOS2 (0.58) NOS2
SCHEMBL5190635 0.91 NOS2 (0.57) NOS2
SCHEMBL5192119 0.91 NOS2 (0.57) NOS2
SCHEMBL5194271 0.88 NOS2 (0.53) NOS2
SCHEMBL5190402 0.88 NOS2 (0.63) NOS2
SCHEMBL5192945 0.87 NOS2 (0.75) NOS2
SCHEMBL5189733 0.86 NOS2 (0.77) NOS2
SCHEMBL27438537 0.86 NOS2 (0.73) NOS2
SCHEMBL5192691 0.86 NOS2 (0.65) NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1754703-A2 N-Heterocyclic derivatives as nos inhibitors Berlex, Inc. (US) 2007-02-21 EP claimed
EP-1754703-A2 N-Heterocyclic derivatives as nos inhibitors Berlex, Inc. (US) 2007-02-21 EP disclosed
EP-0968206-B1 N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS BERLEX LAB (US) 2006-11-15 EP disclosed